Literature DB >> 6689835

The incidence of treated end stage renal disease in the eastern United States: 1973-1979.

T Sugimoto, S J Rosansky.   

Abstract

Incidence rates of treated end stage renal disease (ESRD) by age, sex, race, and reported primary etiology were analyzed for 20 contiguous Eastern States for the period 1973-1979. For White males and females rates have stabilized at 60 and 40 per million person-years, respectively, since 1977. The incidence rates for Blacks (125 per million person-years in males, and 100 in females in 1979), for hypertensive and diabetic nephropathy patients, and for the 65+ age group continue to increase. Higher incidence rates in males were noted for both races during the entire study period. Blacks had twice as high an incidence of treated ESRD as Whites, primarily due to hypertensive and diabetic nephropathy patients (7 and 2.5 times higher, respectively).

Entities:  

Mesh:

Year:  1984        PMID: 6689835      PMCID: PMC1651392          DOI: 10.2105/ajph.74.1.14

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  An areawide survey of treated end-stage renal disease.

Authors:  J S Mausner; J K Clark; B I Coles; H Menduke
Journal:  Am J Public Health       Date:  1978-02       Impact factor: 9.308

2.  Demographic analysis: end-stage renal disease and its treatment in the United States.

Authors:  B T Burton; G H Hirschman
Journal:  Clin Nephrol       Date:  1979-02       Impact factor: 0.975

3.  Medicare end-stage renal disease program: more than a billion dollar question.

Authors:  C R Blagg; B H Scribner
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

4.  Racial differences in the incidence of treatment for end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

5.  Complications of dialysis.

Authors:  G H Hirschman; M Wolfson; J E Mosimann; C B Clark; M L Dante; R J Wineman
Journal:  Clin Nephrol       Date:  1981-02       Impact factor: 0.975

6.  Renal rehabilitation--where are the data?

Authors:  D Rennie
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

7.  Treatment of end-stage renal disease: free but not equal.

Authors:  A S Relman; D Rennie
Journal:  N Engl J Med       Date:  1980-10-23       Impact factor: 91.245

8.  Racial factors in the incidence and causation of end-stage renal disease (ESRD).

Authors:  R E Easterling
Journal:  Trans Am Soc Artif Intern Organs       Date:  1977

9.  The impact of heroin abuse on a regional end-stage renal disease program.

Authors:  M A Zielezny; E E Cunningham; R C Venuto
Journal:  Am J Public Health       Date:  1980-08       Impact factor: 9.308

10.  Implications for health care policy. A social and demographic profile of hemodialysis patients in the United States.

Authors:  R W Evans; C R Blagg; F A Bryan
Journal:  JAMA       Date:  1981-02-06       Impact factor: 56.272

View more
  9 in total

1.  Ten Tanzanian transplants: problems and perspectives.

Authors:  S L Basinda; E E Maro; D G McLarty; A E Young; A J Wing
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

2.  The pathogenesis and prevention of diabetic nephropathy.

Authors:  R Omachi
Journal:  West J Med       Date:  1986-08

3.  The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.

Authors:  R Ferguson; C E Grim; T J Opgenorth
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

4.  End state renal disease: how many, how much?

Authors:  R L Berg; D B Ornt
Journal:  Am J Public Health       Date:  1984-01       Impact factor: 9.308

Review 5.  The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.

Authors:  P R Gwilt; R R Nahhas; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

6.  Epidemiologic features of treated end-stage renal disease in a large prepaid health plan.

Authors:  J D Ordonez; R A Hiatt; C P Quesenberry
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

Review 7.  End-stage renal disease and race: an overview and perspective.

Authors:  R Ferguson
Journal:  J Natl Med Assoc       Date:  1991-09       Impact factor: 1.798

8.  Group participation and survival among patients with end-stage renal disease.

Authors:  R Friend; Y Singletary; N R Mendell; H Nurse
Journal:  Am J Public Health       Date:  1986-06       Impact factor: 9.308

9.  Factors affecting the availability and use of hemodialysis facilities.

Authors:  P D Cleary; M Schlesinger; D Blumenthal
Journal:  Health Care Financ Rev       Date:  1991
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.